(19)
(11) EP 1 863 939 A2

(12)

(88) Date of publication A3:
10.05.2007

(43) Date of publication:
12.12.2007 Bulletin 2007/50

(21) Application number: 06748451.9

(22) Date of filing: 20.03.2006
(51) International Patent Classification (IPC): 
C12Q 1/68(2006.01)
A61K 9/20(2006.01)
(86) International application number:
PCT/US2006/009913
(87) International publication number:
WO 2006/102177 (28.09.2006 Gazette 2006/39)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK YU

(30) Priority: 22.03.2005 US 664248 P
05.12.2005 US 742401 P

(71) Applicants:
  • Novartis AG
    4056 Basel (CH)
  • NOVARTIS-PHARMA GMBH
    1230 Vienna (AT)

    AT 

(72) Inventors:
  • GU, Jessie
    Framingham, MA 01702 (US)
  • MEYER, Joanne
    Framingham, MA 01702 (US)

(74) Representative: Crawley, Patrick Edward et al
Novartis AG Corporate Intellectual Property
4002 Basel
4002 Basel (CH)

   


(54) BIOMARKERS FOR EFFICACY OF ALISKIREN AS A HYPERTENSIVE AGENT